Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

32 trials with published results (14%)

Research Maturity

159 completed trials (69% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.2%

12 terminated out of 232 trials

Success Rate

93.0%

+6.5% vs benchmark

Late-Stage Pipeline

19%

44 trials in Phase 3/4

Results Transparency

20%

32 of 159 completed with results

Key Signals

32 with results93% success12 terminated

Data Visualizations

Phase Distribution

168Total
Not Applicable (78)
Early P 1 (1)
P 1 (21)
P 2 (24)
P 3 (19)
P 4 (25)

Trial Status

Completed159
Unknown28
Recruiting16
Terminated12
Active Not Recruiting8
Not Yet Recruiting5

Trial Success Rate

93.0%

Benchmark: 86.5%

Based on 159 completed trials

Clinical Trials (232)

Showing 20 of 20 trials
NCT07631377Phase 4Not Yet Recruiting

The LalelaLung Study: Digital Stethoscope Clinical Evaluation

NCT04365101Phase 1Terminated

Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19

NCT05797246Phase 2Active Not Recruiting

Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

NCT06274619Not ApplicableCompletedPrimary

Novel Mucosal Correlates Of RSV Protection In Older Adults

NCT05064631Phase 2CompletedPrimary

Bacterial Lysate In Preventing Asthma

NCT05914324Not ApplicableActive Not Recruiting

Outpatient Pediatric Pulse Oximeters in Africa

NCT05422326Phase 2Completed

A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or Unprimed

NCT00448981Not ApplicableCompletedPrimary

Stopping Upper Respiratory Infections and Flu in the Family: The Stuffy Trial

NCT07215871Phase 1Enrolling By Invitation

Rechallenge With a Low Pathogenicity Avian H10N7 Influenza Virus in Healthy Human Volunteers Previously Challenged With H10N7 Influenza

NCT05864118Not ApplicableActive Not RecruitingPrimary

Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory Viruses

NCT07532941Phase 4Not Yet Recruiting

Clinical Efficacy of Stopping Oral Antibiotics When Symptoms Stop, Compared to 'Finishing the Course'

NCT07489846CompletedPrimary

Xpert® ERP on the GeneXpert® System

NCT05677763Phase 4Active Not RecruitingPrimary

OM-85 in Paediatric Recurrent Respiratory Tract Infections With Wheezing Lower Respiratory Illness

NCT06715306Not ApplicableRecruitingPrimary

Intravenous Versus Oral Treatment of the Main Acute Infections

NCT06739499Active Not Recruiting

Bern, Get Ready (BEready) Cohort Study for Pandemic Preparedness

NCT06070688Not ApplicableRecruitingPrimary

An Adjunct Test Distinguishing Bacterial From Viral Etiology Improves Resource Utilization and Efficiency in the ED.

NCT07207291Phase 1Recruiting

Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese Healthy Volunteers

NCT06570889Phase 3Recruiting

VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma

NCT06149494Phase 2Completed

RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection

NCT06560255Phase 3Recruiting

Fish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma

Scroll to load more

Research Network

Activity Timeline